As global connectivity increasingly exposes populations to diverse and rapidly evolving infections, understanding how genetic variation shapes immune responses is vital for developing effective, inclusive vaccines and treatments. 

Ibn Rushd Assistant Professor Fahd Al Qureshah said the field of immunogenetics and immunoengineering holds the potential to create innovative diagnostic and therapeutic approaches that translate genetic discoveries into tangible clinical benefits. 

The newly appointed KAUST faculty member for Bioscience said that his work aligns closely with a core mission of the Biological and Environmental Science and Engineering (BESE) Division: to advance precision medicine and improve human health through bioscience. 

“This is an inspiring time for science in Saudi Arabia, as the nation accelerates its progress toward Saudi Vision 2030 with a strong commitment to research, innovation, and global impact,” Al Qureshah said, adding that he is proud to contribute to this vision and help position Saudi Arabia as a hub of biomedical innovation and excellence. 

“KAUST stands at the forefront of this transformation, bringing together exceptional talent, advanced infrastructure, and a collaborative spirit that fuels breakthrough discovery.” 

Through immunoengineering, Al Qureshah’s team at KAUST is developing bioengineered tools to improve the detection and treatment of immune disorders. Ultimately, the Saudi researcher aims to translate genetic discoveries into tangible advances in precision medicine while mentoring the next generation of immunology leaders. 

“I am most inspired by how studying rare immune disorders can uncover the fundamental logic of the human immune system,” said Al Qureshah, who joins KAUST with a master’s degree in immunology from Harvard University and a Ph.D. in immunology from the University of Washington in Seattle. He also completed postdoctoral training at The Rockefeller University in human genetics and infectious diseases. 

These experiences have shaped his commitment to understanding how genetic variation influences immune defense and disease. “Each stage of my journey has strengthened my belief that science is both creative and profoundly human centered,” Al Qureshah said. “Studying both rare and common immune disorders has shown me how individual cases can illuminate universal principles of biology and health.” 

He added: “I now approach science as a balance of curiosity, precision, purpose, and impact — guided by the goal of transforming discovery into meaningful improvements in people’s lives.” 

Al Qureshah sees his appointment to BESE and KAUST as both a “profound honor and exciting responsibility,” offering an opportunity to build a collaborative research environment grounded in curiosity, integrity, and innovation. “I look forward to contributing to KAUST’s global vision for scientific excellence and mentoring young scientists who will shape the next generation of discovery and impact.” 

As he continues researching how human genetic variation shapes immune responses to viral infections, Al Qureshah said collaboration is fundamental to meaningful scientific progress. Fortunately, he noted, KAUST offers a unique environment where disciplines converge naturally. 

“Engaging with experts in biology, engineering, and computational sciences sparks innovative ideas and transformative research,” Al Qureshah said. “I also see tremendous potential in national and global partnerships that can translate our discoveries into real-world solutions for improving human health.”